Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis

NARecruitingINTERVENTIONAL
Enrollment

472

Participants

Timeline

Start Date

August 25, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2028

Conditions
Ischemic StrokeVertebral Artery Stenosis
Interventions
PROCEDURE

Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor

All the participants in this group will be performed with extracranial vertebral artery sirolimus-eluting stenting plus medical therapy including aspirin 100mg per day + clopidogrel 75mg per day or ticagrelor 90mg twice per day for 6 months and mono anti-platelet therapy thereafter.

DRUG

Aspirin and clopidogrel or ticagrelor

All the participants in this group will be given medical therapy including aspirin 100mg per day + clopidogrel 75mg per day or ticagrelor 90mg twice per day for 6 months and mono anti-platelet therapy thereafter.

PROCEDURE

mono anti-platelet therapy

mono anti-platelet therapy

Trial Locations (1)

100053

RECRUITING

Xuanwu Hospital, Capital Medical University., Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER